Sumitovant Biopharma Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Sumitovant Biopharma

Access the complete profile.

Sumitovant Biopharma Fast Facts

Revenue	Over $500 million    See Exact Annual Revenue
Employees	500 - 1,000Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325414 Biological Product Manufacturing
Address	151 W 42nd St Fl 15 New York, NY 10036

Note: Revenues for privately held companies are statistical evaluations.


Sumitovant Biopharma's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Sumitovant Biopharma's annual revenues are Over $500 million (see exact revenue data)
• What industry is the company in?
  • Sumitovant Biopharma is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Sumitovant Biopharma Annual Revenue and Growth Rate

Sumitovant Biopharma	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	Over $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Sumitovant Biopharma's revenues are gauged from an analysis of company filings.

Sumitovant Biopharma's Income Statement (based on Industry Averages)

Sumitovant Biopharma P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Sumitovant Biopharma is developing and marketing. Sumitovant Biopharma doesn't have any recent trademark applications, indicating Sumitovant Biopharma is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
SPIROVANT Pharmaceutical preparations for human use for the treatment of cystic fibrosis, and pulmonary diseases, disorders and conditions; biologic preparations for medical and therapeutic purposes for the treatment of cystic fibrosis, and pulmonary diseases, disorders and conditions	09/18/2019
DRUGOME Downloadable computer software for providing, analyzing and generating reports; downloadable computer software for data processing; downloadable computer software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and/or transmission of data, images and information; downloadable computer software for the conversion, analysis, processing, storage and transmission of artificial intelligence; downloadable computer software for database integration; downloadable computer software for creating searchable databases of information and data; downloadable software for analytics in the fields of healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, and for clinical trial and post-market trial data; downloadable computer software featuring electronic computer databases of pharmaceuticals, biomedical research, and for clinical trial and post-market trial data; downloadable computer search engine software for compiling, accessing and providing updated scientific, medical, pharmaceutical and clinical information, and news information of general interest	04/23/2019

See all trademarks and details in the Full Report.

Market Share of Sumitovant Biopharma's Largest Competitors

A competitive analysis shows these companies are in the same general field as Sumitovant Biopharma, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Sumitovant Biopharma. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
PFIZER	New York, NY	100
SUMITOVANT BIOPHARMA	New York, NY	3
ROIVANT SCIENCES	New York, NY	2
TERRASCEND USA	New York, NY	1
KADMON HOLDINGS	New York, NY	0
CALLIDITAS NA ENTERPRISES	New York, NY	0

Future Competition: Sumitovant Biopharma's Fastest Growing Competitors

These companies are in the same general field as Sumitovant Biopharma and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)